Wogenes N Oliveira
Overview
Explore the profile of Wogenes N Oliveira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Santos S, Alencar E, Urtiga S, Oliveira W, Miranda J, Amaral-Machado L, et al.
AAPS PharmSciTech
. 2025 Mar;
26(3):84.
PMID: 40074961
Amphotericin B (AmB), a potent amphiphilic drug with antifungal and antileishmanial properties, exhibits reduced nephrotoxicity when delivered via lipid-based systems like microemulsions (ME). However, the complexity of these multi-phasic systems...
2.
Souza L, de Oliveira Bento A, Lourenco E, Ferreira M, Oliveira W, Soares L, et al.
PLoS One
. 2024 Aug;
19(8):e0303878.
PMID: 39137202
The limited arsenal of antifungal drugs have prompted the search for novel molecules with biological activity. This study aimed to characterize the antifungal mechanism of action of Eugenia uniflora extract...
3.
Rodrigues V, Oliveira W, Pereira D, Alencar E, Porto D, Aragao C, et al.
Pharmaceutics
. 2023 Jan;
15(1).
PMID: 36678788
Copaiba oil has been largely used due to its therapeutic properties. Nanocapsules were revealed to be a great nanosystem to carry natural oils due to their ability to improve the...
4.
Amaral-Machado L, Oliveira W, Torres-Rego M, Furtado A, Alencar E, Fernandes-Pedrosa M, et al.
Int J Nanomedicine
. 2021 Nov;
16:7353-7367.
PMID: 34754189
Background: Although bullfrog oil (BFO) exerts anti-inflammatory effects, it has undesirable properties limiting its use. Methodology: BFO nanocapsules (BFONc) were produced through nanoprecipitation, and their physicochemical and morphological properties were...
5.
Souza A, Ribeiro R, Pinheiro G, Pinheiro F, Oliveira W, Souza L, et al.
Pharmaceutics
. 2021 Jun;
13(6).
PMID: 34073997
Onychomycosis induced by spp. has several limitations regarding its treatment. Nail lacquers display the potential to overcome these drawbacks by providing therapeutic compliance and increasing local drug bioavailability. Thus, this...
6.
Amaral-Machado L, Oliveira W, Rodrigues V, Albuquerque N, Alencar E, Egito E
Biomed Pharmacother
. 2020 Dec;
134:111143.
PMID: 33360048
Background: The ARDS (Acute Respiratory Distress Syndrome) is a severe respiratory syndrome that was recently associated as the main death cause in the COVID-19 pandemic outbreak. Hence, in order to...
7.
Amaral-Machado L, Oliveira W, Moreira-Oliveira S, Pereira D, Alencar E, Tsapis N, et al.
Evid Based Complement Alternat Med
. 2020 Feb;
2020:1021258.
PMID: 32104188
Asthma, a disease classified as a chronic inflammatory disorder induced by airway inflammation, is triggered by a genetic predisposition or antigen sensitization. Drugs currently used as therapies present disadvantages such...
8.
Barbosa L, Amaral-Machado L, Felix-Silva J, Oliveira W, Alencar E, Rocha K, et al.
J Oleo Sci
. 2020 Jan;
69(2):133-142.
PMID: 31941865
Bullfrog oil (BFO) is a natural product from the adipose tissue of the amphibian Rana catesbeiana Shaw, a bio-product rich in polyunsaturated fatty acids, which claims anti-inflammatory activity. The objective...
9.
Amaral-Machado L, Oliveira W, Alencar E, Cruz A, Rocha H, Ebeid K, et al.
Biomed Pharmacother
. 2019 Jun;
117:109103.
PMID: 31203130
Bullfrog oil, an animal oil extracted from the adipose tissue of Rana catesbeiana Shaw, showed promising cytotoxic activity against melanoma cells and, therefore, has the potential to become a pharmaceutical...
10.
Oliveira W, Amaral-Machado L, Alencar E, Marcelino H, Genre J, Silva-Rocha W, et al.
AAPS PharmSciTech
. 2018 Jun;
19(6):2585-2597.
PMID: 29916194
Amphotericin B (AmB), a potent antifungal drug, presents physicochemical characteristics that impair the development of suitable dosage forms. In order to overcome the AmB insolubility, several lipid carriers such as...